Saha Depanwita, Talukdar Debojit, Mukherjee Poulami, Mitra Debarpan, Mukherjee Rimi, Guha Subhabrata, Bhattacharjee Aritri, Naskar Rahul, Kumar Sahu Sumanta, Alam Neyaz, Das Gaurav, Murmu Nabendu
Department of Signal Transduction and Biogenic Amines, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700026, India.
Department of Chemistry and Chemical Biology, Indian Institute of Technology (ISM), Dhanbad 826004, Jharkhand, India.
Eur J Pharm Biopharm. 2025 Feb;207:114625. doi: 10.1016/j.ejpb.2025.114625. Epub 2025 Jan 3.
Complete eradication of aggressive head and neck squamous cell carcinoma (HNSCC) still remains a major challenging problem due to numerous resistance properties of cancer stem cells (CSC) which is crucially responsible for tumor recurrence and metastasis. This challenge causes a high demand for the emergence of novel targeted treatment modalities for improved therapeutic efficacies. Phytochemicals derived from plants proves to be a wide reservoir of important drug candidates which have the potential to impede multiple aspects of malignant growth and progression. In the present study, we aimed to synthesize gold nanoparticles in a rapid and cost-effective manner by utilizing Madhuca indica flower extract and to evaluate its anticancer efficacy on head and neck cancer model via targeting cancer stemness and EMT. The phytochemicals present in the Madhuca indica flower extract acted as an effective reducing agent helping in the green synthesis of gold nanoparticles. The generated AuNPs were characterized by UV-Vis spectroscopy, XRD, FTIR, TEM, FE-SEM, DLS, EDX. Anti cancer potential of synthesized AuNPs were evaluated by in vitro and ex vivo HNSCC model. In vivo toxicity was assessed in Swiss albino mice model. The gold nanoparticles were characterized using UV-Vis spectroscopy which revealed unique wavelength maxima at 550 nm and its crystalline nature was confirmed by XRD. AuNPs were observed to be spherical in shape with the mean diameter of 20.34 ± 4.36 nm and zeta potential of nearly -50 mV. The FTIR spectral shift indicated the incorporation of various functional groups. MI-AuNP depicted strong anticancer attributes against HNSCC cell lines SCC154 and FaDu through significant inhibition of cancer stemness and EMT as evident from decreased tumor sphere forming efficiency and CD44+/CD24- subpopulation along with dose dependent downregulated expression of relevant CSC markers and EMT markers both in vitro and ex vivo HNSCC model. Additionally, no evidence of in vivo toxicity has been observed with MI-AuNP administration. In conclusion, this study reported for the first time that the MI-AuNP synthesized by novel green chemistry can efficiently prevent the self-renewal capability of HNSCC by targeting Cancer stemness. The scientific significance of this study lies in the fact that MI-AuNP might be a novel and potential therapeutic candidate against aggressive and metastatic HNSCC. The findings in this study unravels the way for developing a novel therapeutic candidate against aggressive and metastatic HNSCC with a much higher prognostic potential and significantly reduced off target toxicity.
由于癌症干细胞(CSC)具有多种耐药特性,其对肿瘤复发和转移起着至关重要的作用,因此彻底根除侵袭性头颈部鳞状细胞癌(HNSCC)仍然是一个重大挑战。这一挑战使得人们对新型靶向治疗方式的出现有了很高的需求,以提高治疗效果。植物来源的植物化学物质被证明是重要药物候选物的丰富来源,它们有可能阻碍恶性肿瘤生长和进展的多个方面。在本研究中,我们旨在利用印度马胡卡花提取物快速且经济高效地合成金纳米颗粒,并通过靶向癌症干性和上皮-间质转化(EMT)来评估其对头颈癌模型的抗癌效果。印度马胡卡花提取物中存在的植物化学物质作为一种有效的还原剂,有助于金纳米颗粒的绿色合成。所生成的金纳米颗粒通过紫外-可见光谱、X射线衍射(XRD)、傅里叶变换红外光谱(FTIR)、透射电子显微镜(TEM)、场发射扫描电子显微镜(FE-SEM)、动态光散射(DLS)、能量色散X射线光谱(EDX)进行表征。通过体外和体内HNSCC模型评估合成的金纳米颗粒的抗癌潜力。在瑞士白化小鼠模型中评估体内毒性。使用紫外-可见光谱对金纳米颗粒进行表征,结果显示在550nm处有独特的最大波长,XRD证实了其晶体性质。观察到金纳米颗粒呈球形,平均直径为20.34±4.36nm,zeta电位接近-50mV。FTIR光谱位移表明各种官能团的掺入。MI-AuNP对HNSCC细胞系SCC154和FaDu表现出强大的抗癌特性,通过显著抑制癌症干性和EMT,这在体外和体内HNSCC模型中表现为肿瘤球形成效率降低以及CD44+/CD24-亚群减少,同时相关CSC标志物和EMT标志物的表达呈剂量依赖性下调。此外,未观察到MI-AuNP给药有体内毒性的证据。总之,本研究首次报道通过新型绿色化学合成的MI-AuNP可以通过靶向癌症干性有效预防HNSCC的自我更新能力。本研究的科学意义在于MI-AuNP可能是一种针对侵袭性和转移性HNSCC的新型潜在治疗候选物。本研究的结果为开发一种针对侵袭性和转移性HNSCC的新型治疗候选物开辟了道路,该候选物具有更高的预后潜力且显著降低脱靶毒性。
Artif Cells Nanomed Biotechnol. 2020-12
Artif Cells Nanomed Biotechnol. 2017-8-8
BMC Complement Med Ther. 2024-10-1
Mater Sci Eng C Mater Biol Appl. 2019-1-25